🇪🇺 tadalafil once a day [T(OaD)] in European Union

EMA authorised tadalafil once a day [T(OaD)] on 12 November 2002

Marketing authorisation

EMA — authorised 12 November 2002

  • Application: EMEA/H/C/000436
  • Marketing authorisation holder: Eli Lilly Nederland B.V.
  • Local brand name: Cialis
  • Indication: Treatment of erectile dysfunction. In order for tadalafil to be effective, sexual stimulation is required. Cialis is not indicated for use by women.
  • Status: approved

Read official source →

tadalafil once a day [T(OaD)] in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is tadalafil once a day [T(OaD)] approved in European Union?

Yes. EMA authorised it on 12 November 2002.

Who is the marketing authorisation holder for tadalafil once a day [T(OaD)] in European Union?

Eli Lilly Nederland B.V. holds the EU marketing authorisation.